DDrare: Database of Drug Development for Rare Diseases

告示番号	疾患名（ページ内リンク）	臨床試験数
97	潰瘍性大腸炎	1

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT02442960 (ClinicalTrials.gov)	December 2014	23/4/2015	Evaluating Safety and Efficacy of Herbal Treatment in Ulcerative Colitis	An Open-Label, Dose-Escalation Phase Ib Study Evaluating the Safety and Preliminary Efficacy of Oral SA100 in the Treatment of Patients With Mild, Moderate or Severe Ulcerative Colitis	Ulcerative Colitis	Drug: Herbal treatment (SA100)	Stanford University	NULL	Completed	13 Years	75 Years	All	15	Phase 1	United States

No.

TrialID

Date_
enrollment

Date_
registration

Public_title

Scientific_title

Condition

Intervention

Primary_
sponsor

Secondary_
sponsor

Recruitment_
Status

Inclusion_
agemin

Inclusion_
agemax

Inclusion_
gender

Target_
size

Phase

Countries

NCT02442960
(ClinicalTrials.gov)

December 2014

23/4/2015

Evaluating Safety and Efficacy of Herbal Treatment in Ulcerative Colitis

An Open-Label, Dose-Escalation Phase Ib Study Evaluating the Safety and Preliminary Efficacy of Oral SA100 in the Treatment of Patients With Mild, Moderate or Severe Ulcerative Colitis

Ulcerative Colitis

Drug: Herbal treatment (SA100)

Stanford University

NULL

Completed

13 Years

75 Years

All

Phase 1

United States